Saudi medical journal · 2025
Validity and reliability of the Arabic version of topical corticosteroid phobia (TOPICOP©) questionnaire.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Al-Dujaily Hashem M, Hussein Huda A, Abdelrahim Bahaa, Shawer Mohammad, Mehyar Ahmad, Aljeradat Baha', Batarseh Dima, Khraim Sarah, Abdeen Amjad, Almaani Noor
Аннотация
OBJECTIVES: To translate the topical corticosteroid phobia (TOPICOP) scale into Arabic and assess its validity, reliability, and feasibility.
METHODS: A cross-sectional study was carried out at Jordan University Hospital, Amman, Jordan, in 2 phases. Phase one involved translation of the TOPICOP scale into Arabic using a 2-step process, followed by pilot testing and content validation by 6 bilingual dermatologists. Phase 2 involved subsequent validation and feasibility testing on a larger sample of 145 participants. To assess reliability, the scale was administered twice for test-retest analysis.
RESULTS: Calculated content validity indices revealed satisfactory values, establishing content validation of the Arabic version. Cronbach's alpha coefficient indicated reliable internal consistency (0.757). Test-retest reliability yielded a Pearson's correlation coefficient of 0.775 (p<0.001). The mean global TOPICOP score was 56.4%. The scale was clear, feasible, and completed in under 5 minutes without difficulty.
CONCLUSION: The Arabic TOPICOP scale is a valid, reliable, and effective tool for assessing corticosteroid phobia in Arabic-speaking populations. Its implementation can enhance understanding of patient adherence and improve eczema treatment outcomes, benefiting healthcare providers, including dermatologists, general practitioners, and family physicians.
METHODS: A cross-sectional study was carried out at Jordan University Hospital, Amman, Jordan, in 2 phases. Phase one involved translation of the TOPICOP scale into Arabic using a 2-step process, followed by pilot testing and content validation by 6 bilingual dermatologists. Phase 2 involved subsequent validation and feasibility testing on a larger sample of 145 participants. To assess reliability, the scale was administered twice for test-retest analysis.
RESULTS: Calculated content validity indices revealed satisfactory values, establishing content validation of the Arabic version. Cronbach's alpha coefficient indicated reliable internal consistency (0.757). Test-retest reliability yielded a Pearson's correlation coefficient of 0.775 (p<0.001). The mean global TOPICOP score was 56.4%. The scale was clear, feasible, and completed in under 5 minutes without difficulty.
CONCLUSION: The Arabic TOPICOP scale is a valid, reliable, and effective tool for assessing corticosteroid phobia in Arabic-speaking populations. Its implementation can enhance understanding of patient adherence and improve eczema treatment outcomes, benefiting healthcare providers, including dermatologists, general practitioners, and family physicians.